Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacob Lavee

Showing results (91-100 of 116) with videos related to

Pageof 12
Sort By:
Journal of Cardiothoracic Surgery|April 7, 2021
Unusual complications following left ventricular assisted device implantation: case seriesAmjad Shalabi, Erez Kachel, Yigal Kassif, et al.
Harefuah|December 20, 2007
[Criteria for the acceptable heart donor: maximizing the use of hearts recovered from potential donors in Israel]Tuvia Ben Gal, Noah Liel-Cohen, Daniel Admon, et al.
Frontiers in Cardiovascular Medicine|May 13, 2022
Hemodynamic Changes After Left Ventricular Assist Device Implantation Among Heart Failure Patients With and Without Elevated Pulmonary Vascular ResistanceAvishay Grupper, Israel Mazin, Kobi Faierstein, et al.
European Heart Journal|November 30, 2023
Fully magnetically centrifugal left ventricular assist device and long-term outcomes: the ELEVATE registryJan D Schmitto, Steven Shaw, Jens Garbade, et al.
European Heart Journal|October 27, 2020
Two-year outcome after implantation of a full magnetically levitated left ventricular assist device: results from the ELEVATE RegistryDaniel Zimpfer, Finn Gustafsson, Evgenij Potapov, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 12, 2022
Waning humoral immune response to the BNT162b2 vaccine in heart transplant recipients over 6 monthsYael Peled, Eilon Ram, Michal Mandelboim, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 25, 2017
Metformin therapy reduces the risk of malignancy after heart transplantationYael Peled, Jacob Lavee, Eugenia Raichlin, et al.
Clinical Transplantation|October 10, 2017
Early aspirin initiation following heart transplantation is associated with reduced risk of allograft vasculopathy during long-term follow-upYael Peled, Jacob Lavee, Eugenia Raichlin, et al.
Journal of Cardiac Failure|May 18, 2020
Predictors of Physical Capacity 6 Months After Implantation of a Full Magnetically Levitated Left Ventricular Assist Device: An Analysis From the ELEVATE RegistryFinn Gustafsson, Kiran K Mirza, Yuri Pya, et al.
Clinical Transplantation|July 29, 2017
Risk of early, intermediate, and late rejection following heart transplantation: Trends over the past 25 years and relation to changes in medical management. Tertiary center experience: The Sheba Heart Transplantation RegistryMoshe Katz, Dov Freimark, Eugenia Raichlin, et al.
Pageof 12

Showing results (91-100 of 116) with videos related to

Sort By:
Pageof 12
Journal of Cardiothoracic Surgery|April 7, 2021
Unusual complications following left ventricular assisted device implantation: case seriesAmjad Shalabi, Erez Kachel, Yigal Kassif, et al.
Harefuah|December 20, 2007
[Criteria for the acceptable heart donor: maximizing the use of hearts recovered from potential donors in Israel]Tuvia Ben Gal, Noah Liel-Cohen, Daniel Admon, et al.
Frontiers in Cardiovascular Medicine|May 13, 2022
Hemodynamic Changes After Left Ventricular Assist Device Implantation Among Heart Failure Patients With and Without Elevated Pulmonary Vascular ResistanceAvishay Grupper, Israel Mazin, Kobi Faierstein, et al.
European Heart Journal|November 30, 2023
Fully magnetically centrifugal left ventricular assist device and long-term outcomes: the ELEVATE registryJan D Schmitto, Steven Shaw, Jens Garbade, et al.
European Heart Journal|October 27, 2020
Two-year outcome after implantation of a full magnetically levitated left ventricular assist device: results from the ELEVATE RegistryDaniel Zimpfer, Finn Gustafsson, Evgenij Potapov, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 12, 2022
Waning humoral immune response to the BNT162b2 vaccine in heart transplant recipients over 6 monthsYael Peled, Eilon Ram, Michal Mandelboim, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 25, 2017
Metformin therapy reduces the risk of malignancy after heart transplantationYael Peled, Jacob Lavee, Eugenia Raichlin, et al.
Clinical Transplantation|October 10, 2017
Early aspirin initiation following heart transplantation is associated with reduced risk of allograft vasculopathy during long-term follow-upYael Peled, Jacob Lavee, Eugenia Raichlin, et al.
Journal of Cardiac Failure|May 18, 2020
Predictors of Physical Capacity 6 Months After Implantation of a Full Magnetically Levitated Left Ventricular Assist Device: An Analysis From the ELEVATE RegistryFinn Gustafsson, Kiran K Mirza, Yuri Pya, et al.
Clinical Transplantation|July 29, 2017
Risk of early, intermediate, and late rejection following heart transplantation: Trends over the past 25 years and relation to changes in medical management. Tertiary center experience: The Sheba Heart Transplantation RegistryMoshe Katz, Dov Freimark, Eugenia Raichlin, et al.
Pageof 12